Autopsy report · NCT03157856

Assessment of a New Fluorescence Imaging Technique Using Biopsies From Prostate Resection

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Results obtained on the first 8 patients shown an expected glandular membrane specific labeling associated with non-specific labeling of fibro-muscular tissue.”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 1 year 8 months before it stopped.
8 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Sponsor: University Hospital, Grenoble
Sponsor type: University, hospital or other
Conditions: Cancer Prostate
Interventions: Fluorescence assessment
Participants: 8
Sites: 2
Countries: France

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.